AMERICAN SHARED HOSPITAL SERVICES — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that AMERICAN SHARED HOSPITAL SERVICES filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $19.71M | Mar 29, 2019 |
| FY2018 | Dec 31, 2017 | $19.56M | Mar 29, 2019 |
| FY2018 | Dec 31, 2016 | $18.70M | Mar 29, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $28.08M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $28.34M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $21.33M | Apr 4, 2025 |
| FY2023 | Dec 31, 2022 | $19.75M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $17.63M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $17.84M | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | $20.61M | Apr 6, 2021 |
| FY2019 | Dec 31, 2018 | $19.71M | Apr 3, 2020 |
| FY2019 | Dec 31, 2017 | $19.56M | Apr 3, 2020 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.06M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $9.19M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $9.34M | Apr 4, 2025 |
| FY2023 | Dec 31, 2022 | $8.38M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $6.73M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $4.47M | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | $6.92M | Apr 6, 2021 |
| FY2019 | Dec 31, 2018 | $7.49M | Apr 3, 2020 |
| FY2019 | Dec 31, 2017 | $8.66M | Apr 3, 2020 |
| FY2018 | Dec 31, 2016 | $8.80M | Mar 29, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.55M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $2.19M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $610.0K | Apr 4, 2025 |
| FY2023 | Dec 31, 2022 | $1.33M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $194.0K | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($7.06M) | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | $659.0K | Apr 6, 2021 |
| FY2019 | Dec 31, 2018 | $1.02M | Apr 3, 2020 |
| FY2019 | Dec 31, 2017 | $1.92M | Apr 3, 2020 |
| FY2018 | Dec 31, 2016 | $930.0K | Mar 29, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($3.59M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($2.81M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $270.0K | Apr 4, 2025 |
| FY2023 | Dec 31, 2022 | $2.43M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $1.35M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($9.46M) | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | $1.54M | Apr 6, 2021 |
| FY2019 | Dec 31, 2018 | $1.86M | Apr 3, 2020 |
| FY2019 | Dec 31, 2017 | $2.41M | Apr 3, 2020 |
| FY2018 | Dec 31, 2016 | $3.29M | Mar 29, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.08M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $7.41M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $7.02M | Apr 4, 2025 |
| FY2023 | Dec 31, 2022 | $5.15M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $4.53M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $4.61M | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | $4.06M | Apr 6, 2021 |
| FY2019 | Dec 31, 2018 | $3.99M | Apr 3, 2020 |
| FY2019 | Dec 31, 2017 | $4.32M | Apr 3, 2020 |
| FY2018 | Dec 31, 2016 | $3.80M | Mar 29, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.10M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $167.0K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $5.72M | Apr 4, 2025 |
| FY2023 | Dec 31, 2022 | $7.24M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $6.27M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $9.75M | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | $8.05M | Apr 6, 2021 |
| FY2019 | Dec 31, 2018 | $8.06M | Apr 3, 2020 |
| FY2019 | Dec 31, 2017 | $7.85M | Apr 3, 2020 |
| FY2018 | Dec 31, 2016 | $8.38M | Mar 29, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.63M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $7.94M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $6.27M | Apr 4, 2025 |
| FY2023 | Dec 31, 2022 | $388.0K | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $1.67M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $455.0K | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | $990.0K | Apr 6, 2021 |
| FY2019 | Dec 31, 2018 | $1.58M | Apr 3, 2020 |
| FY2019 | Dec 31, 2017 | $803.0K | Apr 3, 2020 |
| FY2018 | Dec 31, 2016 | $1.04M | Mar 29, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $55.48M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $60.20M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $48.16M | Apr 4, 2025 |
| FY2023 | Dec 31, 2022 | $43.96M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $45.43M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $43.65M | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | $53.78M | Apr 6, 2021 |
| FY2019 | Dec 31, 2018 | $57.50M | Apr 3, 2020 |
| FY2018 | Dec 31, 2017 | $58.18M | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | $60.60M | Mar 28, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $27.79M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $30.17M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $21.88M | Apr 4, 2025 |
| FY2023 | Dec 31, 2022 | $18.33M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $21.19M | Mar 31, 2023 |
| FY2014 | Dec 31, 2014 | $19.37M | Apr 1, 2015 |
| FY2014 | Dec 31, 2013 | $24.38M | Apr 1, 2015 |
| FY2013 | Dec 31, 2012 | $45.21M | Mar 31, 2014 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $24.03M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $25.18M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $22.62M | Apr 4, 2025 |
| FY2023 | Dec 31, 2022 | $21.63M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $19.89M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $19.27M | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | $26.03M | Apr 6, 2021 |
| FY2019 | Dec 31, 2018 | $25.10M | Apr 3, 2020 |
| FY2018 | Dec 31, 2017 | $23.86M | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | $21.50M | Mar 28, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.27M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $1.27M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $1.27M | Apr 4, 2025 |
| FY2023 | Dec 31, 2022 | $1.27M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $1.27M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $1.27M | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | $0 | Apr 6, 2021 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.26M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $5.82M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $3.63M | Apr 4, 2025 |
| FY2023 | Dec 31, 2022 | $3.02M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $1.69M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $1.50M | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | $8.56M | Apr 6, 2021 |
| FY2019 | Dec 31, 2018 | $7.90M | Apr 3, 2020 |
| FY2018 | Dec 31, 2017 | $6.87M | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | $4.95M | Mar 28, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.46M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $11.03M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $13.69M | Apr 4, 2025 |
| FY2023 | Dec 31, 2022 | $12.34M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $8.15M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $3.96M | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | $1.43M | Apr 6, 2021 |
| FY2019 | Dec 31, 2018 | $1.44M | Apr 3, 2020 |
| FY2018 | Dec 31, 2017 | $2.15M | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | $2.87M | Mar 28, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.40M | Mar 31, 2026 |
| FY2024 | Dec 31, 2024 | $20.41M | Apr 4, 2025 |
| FY2023 | Dec 31, 2023 | $13.29M | Apr 1, 2024 |
| FY2022 | Dec 31, 2022 | $13.67M | Mar 31, 2023 |
| FY2021 | Dec 31, 2021 | $15.70M | Mar 30, 2022 |
| FY2020 | Dec 31, 2020 | $4.62M | Apr 6, 2021 |
| FY2019 | Dec 31, 2019 | $3.48M | Apr 3, 2020 |
| FY2018 | Dec 31, 2018 | $5.45M | Mar 29, 2019 |
| FY2017 | Dec 31, 2017 | $6.06M | Mar 28, 2018 |
| FY2016 | Dec 31, 2016 | $7.31M | Mar 27, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Apr 4, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | (1) | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Apr 6, 2021 |
| FY2019 | Dec 31, 2018 | 0 | Apr 3, 2020 |
| FY2019 | Dec 31, 2017 | 0 | Apr 3, 2020 |
| FY2018 | Dec 31, 2016 | 0 | Mar 29, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Apr 4, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | (1) | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Apr 6, 2021 |
| FY2019 | Dec 31, 2018 | 0 | Apr 3, 2020 |
| FY2019 | Dec 31, 2017 | 0 | Apr 3, 2020 |
| FY2018 | Dec 31, 2016 | 0 | Mar 29, 2019 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 6.58M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 6.42M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 6.30M | Apr 4, 2025 |
| FY2023 | Dec 31, 2022 | 6.18M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | 6.05M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | 5.79M | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | 5.82M | Apr 6, 2021 |
| FY2019 | Dec 31, 2018 | 5.71M | Apr 3, 2020 |
| FY2018 | Dec 31, 2017 | 5.71M | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | 5.47M | Mar 28, 2018 |